[{"NetIncomeLoss_1_Q1_USD":-232910000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"GainLossOnSaleOfPropertyPlantEquipment_1_Q1_USD":-4000.0,"InventoryFinishedGoods_0_Q1_USD":2703000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-11624000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":742005000.0,"Depreciation_1_Q1_USD":1340000.0,"ProceedsFromSaleOfShortTermInvestments_1_Q1_USD":743902000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q1_USD":0.0,"AssetsCurrent_0_Q1_USD":1049185000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":35838000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":702000.0,"UnrecognizedTaxBenefits_0_Q1_USD":0.0,"CommonStockSharesIssued_0_Q1_shares":88519172.0,"Assets_0_Q1_USD":1131290000.0,"ShareBasedCompensation_1_Q1_USD":7318000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":16652000.0,"CashAndDueFromBanks_0_Q1_USD":1012587000.0,"DeferredRevenue_0_Q1_USD":16657000.0,"IncreaseDecreaseInOtherCurrentLiabilities_1_Q1_USD":21707000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":88374928.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"ProvisionForDoubtfulAccounts_1_Q1_USD":1000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1967802000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":203852000.0,"InventoryRawMaterials_0_Q1_USD":9588000.0,"InventoryWriteDown_1_Q1_USD":14000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-6227000.0,"AccountsReceivableNetCurrent_0_Q1_USD":8815000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":null,"IncreaseDecreaseInDeferredRevenue_1_Q1_USD":-122000.0,"CommonStockValue_0_Q1_USD":5000.0,"DepositsAssetsNoncurrent_0_Q1_USD":910000.0,"StockIssuedDuringPeriodValueShareBasedCompensationGross_1_Q1_USD":62250000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":1448000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-271000.0,"PaymentsOfStockIssuanceCosts_1_Q1_USD":973000.0,"IncreaseDecreaseInInventories_1_Q1_USD":-502000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-232910000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-230010000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-21226000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":1013420000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":12307000.0,"Liabilities_0_Q1_USD":121620000.0,"ShortTermInvestments_0_Q1_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":162.02,"OtherComprehensiveIncomeLossTax_1_Q1_USD":0.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense_1_Q1_USD":0.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":11512000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0_Q1_shares":7369767.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":7318000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":2900000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-169500000.0,"InventoryWorkInProcess_0_Q1_USD":338000.0,"CostOfRevenue_1_Q1_USD":7505000.0,"LiabilitiesCurrent_0_Q1_USD":92656000.0,"ValueAddedTaxReceivableNoncurrent_0_Q1_USD":23698000.0,"AccountsPayableCurrent_0_Q1_USD":41415000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":14321000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1_Q1_USD":-930000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":702000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":1585000.0,"CashEquivalentsAtCarryingValue_0_Q1_USD":833000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":1014163000.0,"PaymentsToAcquireIntangibleAssets_1_Q1_USD":214000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":29016000.0,"IncomeLossFromEquityMethodInvestments_1_Q1_USD":195000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":3386000.0,"RestrictedCashNoncurrent_0_Q1_USD":743000.0,"CommonStockSharesOutstanding_0_Q1_shares":88519172.0,"CommonStockSharesAuthorized_0_Q1_shares":500000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":20103000.0,"OperatingIncomeLoss_1_Q1_USD":-227092000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":-233105000.0,"InventoryNet_0_Q1_USD":12629000.0,"InvestmentIncomeInterest_1_Q1_USD":214000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":1131290000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":7694000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":40528000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":5602000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-2.64,"OtherLiabilitiesCurrent_0_Q1_USD":45639000.0,"StockholdersEquity_0_Q1_USD":1009670000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":1683000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":2000.0,"LongTermInvestments_0_Q1_USD":1473000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-946513000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":571304000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":3651000.0,"NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_1_Q1_USD":439000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":3274000.0,"Ticker":"ZLAB","CIK":"1704292","name":"ZAI LAB LTD","OfficialName":"Zai Lab Limited American Depositary Shares","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3400943056.0","Country":"China","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210510"}]